Hong Kong faces serious rivals in its bid to become the Asian hub for CBD.
By Mark Andrews
CBD Intel. 14/07/2020
“There appeared to be lots of activity in 2019 around public companies and funds in HK wanting to attach themselves to all things ‘cannabis’, which includes of course hemp and CBD,” CannAcubed CEO Glenn Davies told CBD-Intel. “HK, Shenzhen and Shanghai companies spiked and soared, and stocks rallied when announcements were made regarding the sector.”
Other unsuccessful deals indicated further appetite. These included an attempted $15m takeover of Yooya – a Chinese e-commerce platform that could have been used to sell CBD health products – by Regent Pacific, a Hong Kong exchange listed specialist healthcare, wellness and life sciences investment group.
You can read the full article here
Let’s Get Started
Get in touch with Mark
All articles and photographs displayed on this web site are available for purchase with rights varying according to what has previously been sold. For most published articled this means first serial rights for the country that the publication appears in.
If you wish to speak to me about anything on this website or to discuss commissioning any work I can be contacted by:
Mobile phone
0044 776 162 5426
This is a UK mobile number.
Email Click to email Mark